Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hospira 3Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Hospira 3Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Hospira

3Q Revenues: $838 million (+30%)

3Q Earnings: $59 million (+6%)

YTD Revenues: $2.5 billion (+26%)

YTD Earnings: $61 million (-68%)

Comments: Integration of Mayne Pharma helped drive revenue growth, while restructuring costs drove down earnings. Injectable Pharmaceutical Contract Manufacturing revenues were down 12% to $33.5 million in 3Q and down 20% to $111.6 million YTD.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters